GBT
MRNA icon

Grove Bank & Trust’s Moderna MRNA Stock Holding History

Grove Bank & Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38
Closed -$1.05K – 875
2025
Q2 		$1.05K Buy
+38
New +$1K ﹤0.01% 817
2025
Q1 		– Sell
-13
Closed -$541 – 861
2024
Q4 		$541 Buy
+13
New +$621 ﹤0.01% 736
2023
Q3 		– Sell
-20
Closed -$2.43K – 773
2023
Q2 		$2.43K Hold
20
– – ﹤0.01% 593
2023
Q1 		$3.07K Buy
+20
New +$3.3K ﹤0.01% 610

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Grove Bank & Trust's MRNA Position: Q3 2025 in Review

Grove Bank & Trust sold out of Moderna (MRNA) in Q3 2025, closing a stake of 38 shares — an estimated $1.05K sold.

Grove Bank & Trust first reported a position in MRNA in Q1 2023 and held it in 4 quarters. The position peaked at $3.07K in Q1 2023. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Grove Bank & Trust reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Grove Bank & Trust sold 38 Moderna shares in Q3 2025, an estimated $1.05K.
  • Grove Bank & Trust first reported a position in Moderna in Q1 2023 and held it in 4 quarters.
  • Grove Bank & Trust's Moderna position peaked at $3.07K in Q1 2023.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Grove Bank & Trust's 13F filing for Q3 2025, filed 6 Oct 2025.